UNSPSC 51271619: Zucapsaicin

This classification denotes an analgesic agent with the molecular formula C18H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15OX67P384, chemically known as 6-nonenamide, n-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (z)- but generally known as zucapsaicin, which bears US NIH Compound Identifier 1548942. European Medicines Agency schedules Zucapsaicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00193MIG.

UNSPSC 51271619 Zucapsaicin is a Commodity code that encompasses pharmaceuticals and active pharmaceutical ingredients sourced through state and local cooperative purchasing agreements. Recent activity shows state and local governments buying generic multi-source pharmaceutical products and over-the-counter medications through established wholesaler networks, with vendors required to supply products bearing specific National Drug Codes (NDCs), stock-keeping units (SKUs), and universal product codes (UPCs) that meet current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance. The issuing bodies soliciting under this code include state purchasing offices administering multistate cooperative purchasing vehicles. The Minnesota Department of Administration's Office of State Procurement, through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), is a primary buyer consolidating demand across multiple participating state and local government facilities in Minnesota and Oregon, among others.

The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline. Vendors must maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), certify cGMP and DSCSA compliance, carry commercial general liability insurance of $5 million per occurrence, and accept a 3 percent administrative fee on all contract purchases. Pricing is weighted at 75 percent of evaluation, with the remaining 25 percent split among fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and agreement to administrative fees (5 percent). The contract term is two years for new vendors, with optional extensions at MMCAP's discretion, and awarded vendors are expected to provide products to wholesalers by May 15, 2026, with agreements effective July 1, 2026.